Posted in | News | Nanoanalysis

Malvern Secures £3 Million Support from The UK Government’s Regional Growth Fund (RGF)

Malvern Panalytical (Malvern Panalytical, Worcestershire, UK) has been successful in securing £3 million support from the UK Government’s Regional Growth Fund (RGF) that will lead to the creation of 47 new jobs in the UK over the next five years.

Malvern Panalytical develops, manufactures and markets materials and biophysical characterization systems. These are used to measure particle size, particle shape, zeta potential, protein charge, molecular weight, mass, size and conformation, rheology and for chemical identification.

This funding will support the research and development of new analytical instrumentation to serve the fast-growing nanomaterials and bioscience sectors, helping maximize Malvern Panalytical’s export opportunities in these global markets. The company, which currently employs around 340 people in the UK and approaching 480 more in locations around the world, has already started recruiting to fill a variety of new posts.

“This major boost for Malvern Panalytical enables us make significant investments in UK R&D, applications development and manufacturing engineering, to extend our links with UK universities and schools and to invest further in our apprentice programme,” said Managing Director Paul Walker. “It is good news not just for the company but also for the wider community in creating and securing employment opportunities and contributing further to the local economy.”

Malvern Panalytical’s systems are used in research, development and manufacturing across many different industries. They provide information that is critical for developing new products, as well as for enhancing and maintaining product quality and improving process efficiency.

“The Bioscience and Nanomaterials markets require novel analytical techniques and the RGF funding will support our fundamental research in these areas, as well as enabling us to further develop the skills of new and existing employees,” continued Paul Walker. “Not only will we be looking to recruit additional R&D scientists, we are also creating new jobs in manufacturing engineering and operations to enable us to bring new products to market.”

Headquartered in Malvern Panalytical UK, Malvern Panalytical is a market leading company with a global reputation for high quality analytical instrumentation, supported by extensive technical and applications expertise. It exports more than 95% of its output and has subsidiaries in all major European markets, North America, China, Japan and Korea, a joint venture in India, a global distributor network and applications laboratories around the world.

To find out more about working for Malvern Panalytical contact [email protected] or visit www.malvern.com for details of the company and its products.

The Regional Growth Fund is a £3.2 billion fund designed to help companies in England grow and supports projects and programmes committed to delivering sustainable jobs and economic growth. A sixth round will launch in summer. For more information please go to www.bis.gov.uk/rgf

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Malvern Panalytical. (2019, February 11). Malvern Secures £3 Million Support from The UK Government’s Regional Growth Fund (RGF). AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=30164.

  • MLA

    Malvern Panalytical. "Malvern Secures £3 Million Support from The UK Government’s Regional Growth Fund (RGF)". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=30164>.

  • Chicago

    Malvern Panalytical. "Malvern Secures £3 Million Support from The UK Government’s Regional Growth Fund (RGF)". AZoNano. https://www.azonano.com/news.aspx?newsID=30164. (accessed November 21, 2024).

  • Harvard

    Malvern Panalytical. 2019. Malvern Secures £3 Million Support from The UK Government’s Regional Growth Fund (RGF). AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=30164.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.